ToorajJosephRaoofMDinternal medicine

Dermatology • Encino, CA

Cosmetic Dermatology

Pi

Join to view full profile

Dr. Raoof is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Raoof's full profile

Already have an account?

Office
16133 Ventura Blvd
340
Encino, CA 91436
Phone+1 818-788-5060

Fax+1 818-783-8676

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1986 - 1987
Shiraz University of Medical SciencesClass of 1977

Certifications & Licensure

CA State Medical License 1986 - 2025
NJ State Medical License 1986 - 1991

Clinical Trials

DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis Start of enrollment: 2014 Jan 01
Completed
Phase 2
12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01
Completed
Phase 3
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
Terminated
Phase 3
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
Completed
Phase 2
A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2 Start of enrollment: 2019 Nov 13
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

19 citations
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.
John E. Jett, Michael McLaughlin, Mark S. Lee, Lawrence Charles Parish, Janet DuBois
American Journal of Clinical Dermatology. 2021-10-28
27 citations
Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study
Tooraj Joseph Raoof, Deirdre Hooper, Angela Yen Moore, Martin Zaiac, Tory P. Sullivan
Journal of the American Academy of Dermatology. 2020-04-01
19 citations
A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis.
Robert Bissonnette, Robert S Call, Tooraj Raoof, Zhaoyin Zhu, Swamy Yeleswaram
American Journal of Clinical Dermatology. 2022-05-01